Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro

Chronic myeloid leukaemia (CML) is a form of leukaemia derived from the myeloid cell lineage. Imatinib mesylate, the breakpoint cluster region-abelson murine leukeamia kinase inhibitor, is a specific reagent used in the clinical treatment of CML. The DNA topoisomerase II inhibitor, etoposide, is als...

Descripción completa

Detalles Bibliográficos
Autores principales: Husaini, Roslina, Ahmad, Munirah, Zakaria, Zubaidah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450554/
https://www.ncbi.nlm.nih.gov/pubmed/28587395
http://dx.doi.org/10.3892/etm.2017.4443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450554/
https://www.ncbi.nlm.nih.gov/pubmed/28587395
http://dx.doi.org/10.3892/etm.2017.4443

Ejemplares similares